Dexcom Rival Fights Its Bid To Tweak Glucose Monitor Patent

By Jamie Lennox · February 28, 2024, 7:51 PM GMT

A Korean medical tech company has asked a London court to block Dexcom's bid to tweak its diabetes management patent to avoid losing protections should the court rule that it's invalid....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Patchwork of Pre-Embryo Rulings Challenges Courts No Photo Available

Mark Payne

As a greater number of couples who can't naturally procreate turn to in vitro fertilization, state judges are grappling with an evolvi... (more story)

Joint Operating Deals Get Another Look in Hospital Tie-Ups No Photo Available

Yeji Jesse Lee

Interest in joint operating agreements — sometimes called virtual mergers — is on the rise as more hospitals try to prepare for heavie... (more story)

A New Mental Health Rx? FDA Braces For AI Chatbots No Photo Available

Dan McKay

Patients suffering from depression may someday soon get an unusual kind of prescription that doesn’t involve a pill or an injection: D... (more story)